LumaCyte's mission is to provide researchers with a transformational diagnostic tool that accelerates medical and pharmaceutical discoveries through novel cell analysis and sorting. Our vision is to empower researchers to ask questions and seek answers without the bias of antibody-based diagnostics. Our cell analysis and sorting philosophy is based on the enormous potential of measuring the native response of a cell to its environment and the ability to detect subtle changes in cell morphology, biochemistry, and biophysical properties.
Our values, passion, and drive are based upon the desire to help humankind better understand disease to accelerate therapies and cures.
LumaCyte is an advanced research and analytics instrumentation company headquartered in Charlottesville, VA. LumaCyte produces label-free, single cell analysis and sorting instrumentation where the use of antibody or genetic labelling is not required for cellular analysis. This revolutionary technology utilizes optical forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell. Applications of LumaCyte’s label-free platform technology include viral infectivity for vaccine manufacturing, cancer biology R&D, CAR-T, cell therapy, infectious disease and pre-clinical drug discovery. There are multiple applications for use in manufacturing and quality control to optimize process.